HWAM
Hennion & Walsh Asset Management’s Kiniksa Pharmaceuticals KNSA Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $3.68M | Sell |
133,014
-51,112
| -28% | -$1.41M | 0.15% | 168 |
|
|
2025
Q1 | $4.09M | Sell |
184,126
-15,399
| -8% | -$342K | 0.18% | 138 |
|
|
2024
Q4 | $3.95M | Buy |
199,525
+3,673
| +2% | +$72.7K | 0.18% | 139 |
|
|
2024
Q3 | $4.89M | Buy |
195,852
+13,886
| +8% | +$347K | 0.23% | 100 |
|
|
2024
Q2 | $3.4M | Buy |
181,966
+57,088
| +46% | +$1.07M | 0.17% | 143 |
|
|
2024
Q1 | $2.46M | Buy |
124,878
+28,237
| +29% | +$557K | 0.13% | 213 |
|
|
2023
Q4 | $1.7M | Buy |
96,641
+41,594
| +76% | +$730K | 0.1% | 273 |
|
|
2023
Q3 | $956K | Buy |
55,047
+26,002
| +90% | +$452K | 0.06% | 366 |
|
|
2023
Q2 | $409K | Sell |
29,045
-39,836
| -58% | -$561K | 0.02% | 571 |
|
|
2023
Q1 | $741K | Sell |
68,881
-10,538
| -13% | -$113K | 0.05% | 420 |
|
|
2022
Q4 | $1.19M | Buy |
79,419
+10,041
| +14% | +$150K | 0.07% | 309 |
|
|
2022
Q3 | $891K | Sell |
69,378
-961
| -1% | -$12.3K | 0.06% | 352 |
|
|
2022
Q2 | $682K | Sell |
70,339
-1,045
| -1% | -$10.1K | 0.04% | 415 |
|
|
2022
Q1 | $710K | Buy |
71,384
+1,457
| +2% | +$14.5K | 0.04% | 431 |
|
|
2021
Q4 | $823K | Buy |
69,927
+4,368
| +7% | +$51.4K | 0.04% | 420 |
|
|
2021
Q3 | $747K | Buy |
65,559
+22,443
| +52% | +$256K | 0.04% | 416 |
|
|
2021
Q2 | $601K | Buy |
+43,116
| New | +$601K | 0.03% | 481 |
|